The Evaluation of Recombinant LH Supplementation in Patients With Suboptimal Response to Recombinant FSH Undergoing ICSI
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The investigators aimed to evaluate patients who had In-vitro fertilization treatment and who
had COH (controlled ovarian hyperstimulation) cycles applying long protocol with GnRH
(gonadotropin-releasing hormone) analogue with suboptimal response to the rFSH. The
investigators evaluated and compared the addition of rLH, increasing the dose of rFSH and the
control groups regarding the results of IVF in these patients.
Phase:
Phase 4
Details
Lead Sponsor:
Sisli Etfal Training & Research Hospital Sisli Hamidiye Etfal Training and Research Hospital